Standardize for Success
We’re making progress on standardizing single-use systems – and it could mean a more cost-effective supply chain
Jerry Branscomb | | Opinion
Recent years have seen considerable growth in the adoption of single-use technologies in the biopharmaceutical industry. By eliminating the long, resource-intensive decontamination and sterilization steps associated with multi-use equipment, single-use has proven that it can help biopharmaceutical organizations boost operational efficiency, improve product quality and consistency, and reduce costs. However, increased demand for single-use is straining supply chains and delivery timelines – an issue I believe standardization can alleviate.
Standardization has historically proven challenging because biopharmaceutical organizations typically require highly specialized (often custom) single-use designs to meet their workflow needs. And if standardization practices are not properly executed and managed, it can be difficult to control configurations that have been functionally optimized and qualified for use in multiple applications. If the same design is being used across different workflows and facilities, for example, we must employ appropriate processes to ensure that any subsequent revisions will not impact the various applications.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.